Globalization of Chagas Disease Burden and New Treatment Perspectives
- PMID: 26337998
- DOI: 10.1016/j.jacc.2015.07.024
Globalization of Chagas Disease Burden and New Treatment Perspectives
Similar articles
-
Antiparasitic treatment with itraconazole and amiodarone in 2 dogs with severe, symptomatic Chagas cardiomyopathy.J Vet Intern Med. 2022 May;36(3):1100-1105. doi: 10.1111/jvim.16422. Epub 2022 Apr 7. J Vet Intern Med. 2022. PMID: 35388923 Free PMC article.
-
[Tolerance to benzonidazole during the etiological treatment of Chagas' disease].Arq Bras Cardiol. 1987 Jun;48(6):395-7. Arq Bras Cardiol. 1987. PMID: 3128252 Portuguese. No abstract available.
-
The emerging role of amiodarone and dronedarone in Chagas disease.Nat Rev Cardiol. 2012 Oct;9(10):605-9. doi: 10.1038/nrcardio.2012.108. Epub 2012 Aug 7. Nat Rev Cardiol. 2012. PMID: 22869282 Review.
-
Trypanosoma cruzi: cardiac myocells alterations due to spontaneous or therapeutically induced intracellular parasite disintegration.Cell Mol Biol. 1987;33(6):797-805. Cell Mol Biol. 1987. PMID: 3326682 No abstract available.
-
Clinical aspects of the Chagas' heart disease.Int J Cardiol. 2007 Feb 14;115(3):279-83. doi: 10.1016/j.ijcard.2006.03.004. Int J Cardiol. 2007. PMID: 16769134 Review.
Cited by
-
Host-Directed Drug Therapies for Neglected Tropical Diseases Caused by Protozoan Parasites.Front Microbiol. 2018 Nov 30;9:2655. doi: 10.3389/fmicb.2018.02655. eCollection 2018. Front Microbiol. 2018. PMID: 30555425 Free PMC article. Review.
-
Integration of miRNA and gene expression profiles suggest a role for miRNAs in the pathobiological processes of acute Trypanosoma cruzi infection.Sci Rep. 2017 Dec 21;7(1):17990. doi: 10.1038/s41598-017-18080-9. Sci Rep. 2017. PMID: 29269773 Free PMC article.
-
Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine.PLoS Negl Trop Dis. 2018 Mar 30;12(3):e0006384. doi: 10.1371/journal.pntd.0006384. eCollection 2018 Mar. PLoS Negl Trop Dis. 2018. PMID: 29601585 Free PMC article.
-
Post hoc analyses of SHIFT and PARADIGM-HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: "Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial" by Bocchi et al.ESC Heart Fail. 2018 Dec;5(6):1069-1071. doi: 10.1002/ehf2.12355. Epub 2018 Oct 9. ESC Heart Fail. 2018. PMID: 30298996 Free PMC article. No abstract available.
-
Chagas Cardiomyopathy in Latin America Review.Curr Cardiol Rep. 2019 Feb 12;21(2):8. doi: 10.1007/s11886-019-1095-y. Curr Cardiol Rep. 2019. PMID: 30747287 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources